Literature DB >> 7348575

Relationship among estrogen receptors, proliferative activity and menopausal status in breast cancer.

A Bertuzzi, M G Daidone, G Di Fronzo, R Silvestrini.   

Abstract

Kinetic and estrogen receptor (ER) determinations were performed on 357 primary breast cancers. The proliferative activity of the cell population was determined by the autoradiographic technique and expressed as [3H]thymidine labeling index (LI): the ER status was assessed by the absorption charcoal technique. From the overall analysis of the relationship between proliferative activity and ER status, by using the median LI value as cutoff of low and high proliferating tumors, a correlation between ER + status and low proliferative activity and between ER- status and high proliferative activity was observed in 64% of the cases. Menopausal status proved to be an important determinant of kinetic and ER features. In fact, the proliferative activity was always higher in ER--tumors than in ER + tumors within the same menopausal group, and a decrease in proliferative activity was observed from premenopause to postmenopause within ER + and ER--tumors. The analysis of the relation between ER levels and proliferative activity in ER + tumors also evidenced three main ER/LI clusters significantly related to premenopause, paramenopause and postmenopause. A particular indication of nodal involvement was evidenced for a cluster of tumors with low ER levels and high LI from postmenopausal patients. The three different, previously proposed kinetic groups of potential relevance for prognostic and therapeutic purposes were confirmed and more precisely defined by considering not only premenopause and postmenopause but also paramenopause.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7348575     DOI: 10.1007/bf01806265

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  17 in total

1.  Standards for the assessment of estrogen receptors in human breast cancer. Report of a workshop on September 29, 1972, at the Antoni van Leeuwenhoek-Huis, Amsterdam.

Authors: 
Journal:  Eur J Cancer       Date:  1973-05       Impact factor: 9.162

2.  Hormone receptors: their role in predicting prognosis and response to endocrine therapy.

Authors:  W L McGuire
Journal:  Semin Oncol       Date:  1978-12       Impact factor: 4.929

3.  Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication.

Authors:  J S Meyer; B R Rao; S C Stevens; W L White
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

4.  Receptor and centriole pathways of steroid action in normal and neoplastic cells.

Authors:  I Nenci
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

5.  The relative importance of estrogen receptor analysis as a prognostic factor for recurrence or response to chemotherapy in women with breast cancer.

Authors:  R Hilf; M L Feldstein; S L Gibson; E D Savlov
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

6.  Estrogen-receptor status and response to chemotherapy in early and advanced breast cancer.

Authors:  G Bonadonna; P Valagussa; G Tancini; G Di Fronzo
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

7.  Relationship between proliferative activity and estrogen receptors in breast cancer.

Authors:  R Silverstrini; M G Daidone; G Di Fronzo
Journal:  Cancer       Date:  1979-08       Impact factor: 6.860

8.  Advanced stage and early relapse of breast carcinomas associated with high thymidine labeling indices.

Authors:  J S Meyer; B Hixon
Journal:  Cancer Res       Date:  1979-10       Impact factor: 12.701

9.  Estrogen receptors and responses to chemotherapy and hormonal therapy in advanced breast cancer.

Authors:  D T Kiang; D H Frenning; A I Goldman; V F Ascensao; B J Kennedy
Journal:  N Engl J Med       Date:  1978-12-14       Impact factor: 91.245

10.  Clinical data and estradiol receptor evaluation in breast cancer biopsies.

Authors:  G Di Fronzo; A Bertuzzi; R Saccozzi
Journal:  Tumori       Date:  1979-04-30
View more
  7 in total

Review 1.  Progress in understanding breast cancer: epidemiological and biological interactions.

Authors:  P Boyle; R Leake
Journal:  Breast Cancer Res Treat       Date:  1988-05       Impact factor: 4.872

2.  Transferrin receptor is inversely correlated with estrogen receptor in breast cancer.

Authors:  S E Tonik; J E Shindelman; H H Sussman
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

Review 3.  Practical breast carcinoma cell kinetics: review and update.

Authors:  J S Meyer; R W McDivitt; K R Stone; M U Prey; W C Bauer
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

4.  Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer.

Authors:  R Silvestrini; M G Daidone; G Di Fronzo; A Morabito; P Valagussa; G Bonadonna
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

5.  3H-thymidine labeling index, hormone receptors, and ploidy in breast cancers from elderly patients.

Authors:  B Valentinis; R Silvestrini; M G Daidone; D Coradini; E Galante; A M Cerrotta; G Abolafio; L Arboit
Journal:  Breast Cancer Res Treat       Date:  1991-12       Impact factor: 4.872

6.  Relevance of cell kinetics to hormonal response of receptor-positive advanced breast cancer.

Authors:  A Paradiso; V Lorusso; S Tommasi; F Schittulli; E Maiello; M De Lena
Journal:  Breast Cancer Res Treat       Date:  1988-04       Impact factor: 4.872

7.  Androgen receptor expression in male breast carcinoma: lack of clinicopathological association.

Authors:  A Pich; E Margaria; L Chiusa; G Candelaresi; O Dal Canton
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.